UNSPSC 51453602: Nitroscanate

This classification denotes an antihelminthic agent with the molecular formula C13H8N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P4IE5B6D6U, chemically known as isothiocyanic acid, p-(p-nitrophenoxy)phenyl ester but generally known as nitroscanate, which bears US NIH Compound Identifier 68547. European Medicines Agency schedules Nitroscanate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09328MIG.

UNSPSC 51453602 Nitroscanate, a Commodity code, does not reflect the pharmaceutical and medical supply categories state and local governments are actually procuring under the opportunities posted against this code. Recent solicitations tagged to 51453602 span naloxone procurement, generic pharmaceuticals through cooperative purchasing alliances, direct-to-manufacturer prescription programs, and emergency medical supplies — none of which align with nitroscanate, a veterinary antihelmintic drug. The code shows a material misalignment between its nominal scope and current buying activity, suggesting either systematic tagging errors or that the code is being used as a catch-all for pharmaceutical and medical product procurement outside its intended domain.

The most recent opportunities include the City of Tampa's IFB for medical and first aid supplies ($700,000 estimated value, response deadline March 13, 2026) for the Fire Department Rescue Division; Seminole County, Florida's IFB for naloxone and drug deactivation systems (1,900 units naloxone and 800 deactivation systems annually, response deadline July 26, 2023) through quarterly deliveries; the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (proposal deadline March 26, 2026, available through three authorized wholesalers); and the Texas Health and Human Services Commission's RFI for Therapeutic Pharmacy Initiative direct-to-manufacturer prescription capabilities (response deadline April 3, 2026). Activity centers on Florida (Seminole and Hillsborough counties), Minnesota cooperative purchasing, and Texas state health services, with issuing bodies spanning county health departments, municipal fire departments, and state health agencies. The code shows recent activity but lacks coherent scope alignment with its pharmaceutical taxonomy position.